(Q42666684)

4 November 2017

An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms (English)

1 reference

4 November 2017

0 references

Shouhei Nagaoka

1

1 reference

PubMed ID

24937583

4 November 2017

Mikako Ohno

series ordinal

2

1 reference

PubMed ID

24937583

4 November 2017

Akiko Sekiguchi

series ordinal

3

1 reference

4 November 2017

1 January 2004

1 reference

International Journal of Psychiatry in Clinical Practice

4 November 2017

1 reference

4 November 2017

8

1 reference

4 November 2017

1

1 reference

4 November 2017

47-51

1 reference

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

4 November 2017

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

The prevalence and characteristics of fibromyalgia in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Treatment of fibrositis with fluoxetine hydrochloride (Prozac).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

An open clinical trial of venlafaxine treatment of fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Milnacipran. A review of its use in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

A SELF-RATING DEPRESSION SCALE

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Self-rating depression scale in an outpatient clinic. Further validation of the SDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

The Face Scale: a brief, nonverbal method for assessing patient mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

The relationship between fibromyalgia and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

The West Haven-Yale Multidimensional Pain Inventory (WHYMPI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13651500310004038

10.1080/13651500310004038

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference

PubMed ID

24937583